Behavior
Conduct extensive pain, sensory, motor, and cognitive behavioral testing.
MD Biosciences provides specialized models for post-operative pain (POP), including the Brennan paw incision model in rodents and our advanced translational pig model. The pig shares valuable similarities with humans, such as skin and neurological characteristics, making it an exceptional choice for studying post-surgical pain. Our state-of-the-art facilities and expert team provide a multifaceted approach with clinically relevant assessments, including histology, immunohistochemistry (IHC), biomarker analysis, behavioral assessments, and in vivo electrophysiology. Explore our comprehensive models and assessments designed to deepen the understanding of post-operative pain and drive the development of effective therapies.
The Brennan rodent model of paw incisional pain is a widely recognized and extensively validated tool for studying post-operative pain and evaluating analgesic treatments relevant to human conditions. A one cm incision is made through the skin, fascia, and muscle in the hind paw, replicating surgical tissue injury. This model delivers reliable results through behavioral and sensory assessments, essential for advancing postoperative pain research and therapy development.
The pig model is a valuable translational tool for post-operative pain research due to its physiological and anatomical similarities to humans. We offer two advanced models: the flank incisional model, ideal for evaluating local and topical treatments, and the leg incisional model, which provides a highly sensitive setting for assessing nerve block efficacy and advancing pain management strategies.
The figure shows locomotor activity in the pig POP model at baseline and 2 hours post-treatment. Open field traces indicate a significant reduction in activity for both treatments compared to the vehicle group.
The figure shows withdrawal force decreases after incision in both vehicle and treated groups, indicating increased sensitivity.
MD Biosciences offers comprehensive in vivo measures and endpoint assessments, delivering robust data packages to support critical research decisions in the evolving landscape of drug development and biomedical research.
Conduct extensive pain, sensory, motor, and cognitive behavioral testing.
Explore inflammatory and pain biomarkers in disease-specific tissues.
Characterize tissue and cellular changes in disease, pain, and neurodegeneration.
Measure motor and sensory evoked potentials to assess disease progression and pain.